Delivery Order SPE2DU25D9517-SPE2DU26FEMPF
- Not listed
- The Defense Logistics Agency awarded a $1,988.12 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois. This delivery order, issued December 12, 2025, represents one of numerous purchases under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the DLA's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative. The contract was established...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $8,358 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. This delivery order, issued on December 1, 2025, represents one of numerous orders placed under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative. The...
- The Defense Logistics Agency issued a delivery order valued at $4,255.34 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois. This firm fixed-price delivery order, awarded on December 22, 2025, is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative. The PPV-G GEN V represents a...
- The Defense Logistics Agency issued a delivery order valued at $134,472.28 on December 10, 2025, to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. This firm fixed-price delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract (SPE2DR) established under the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion...
- The Defense Logistics Agency awarded a $12,177.12 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois. This delivery order, issued on November 14, 2025, with an ultimate completion date of November 18, 2025, represents one of multiple purchase orders issued under DMS Pharmaceutical Group's Indefinite Delivery Contract with the DLA. The contract carries no set-aside designation,...
- The Defense Logistics Agency has awarded a firm fixed-price delivery order valued at $2,129.37 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. This delivery order, issued on December 26, 2025, falls under the company's single-award Indefinite Delivery Contract with the DLA's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, which carries a $500 million ceiling and extends through December...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $17,021.36 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. This delivery order, issued on December 17, 2025, represents one of multiple orders executed under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative....
- The Defense Logistics Agency issued a $11,591.04 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois. This delivery order, awarded on November 5, 2025, represents one of multiple orders issued to the vendor under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion Department of Defense pharmaceutical supply acquisition strategy. DMS...
- The Defense Logistics Agency awarded a $10,588.89 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois. This delivery order, issued on December 23, 2025, with an ultimate completion date of December 24, 2025, represents one of numerous purchase orders placed under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA. The delivery order carries no set-aside designation,...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $5,795.49 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. This delivery order, issued on December 15, 2025, with an ultimate completion date of December 16, 2025, was awarded without set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. The delivery order is issued under DMS...
- SPE2DU25D9517Indefinite Delivery Contract
- SPE2DU25D9517-SPE2DU26FEMPFDelivery Order
The Defense Logistics Agency awarded a $25,646.10 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. This delivery order, issued on December 10, 2025, represents one of numerous pharmaceutical supply orders placed under DMS Pharmaceutical Group's broader Indefinite Delivery Contract with the DLA. The contract utilizes no set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. As the sole awardee on this delivery order, DMS Pharmaceutical Group will supply pharmaceutical products and medical consumables to support Department of Defense healthcare operations. This delivery order operates under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract designated SPE2DR, which was awarded on November 13, 2025, as part of the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative. The parent contract carries a $500 million ceiling value and extends through December 31, 2036, positioning DMS Pharmaceutical Group as a critical regional pharmaceutical supplier within the broader $30.3 billion PPV-G GEN V acquisition strategy. The contractor's product portfolio encompasses branded and generic prescription medications, biologics, vaccines, specialty pharmaceuticals, and medical consumables, enabling comprehensive pharmaceutical support for military healthcare facilities worldwide. The performance location for this delivery order is Park Ridge, Illinois, with an ultimate completion date of December 11, 2025.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $25.6k | 12/9/25 |